Results for tag: "Androisoxazole"

Androisoxazole is a class of gastrointestinal drugs used to treat a variety of gastrointestinal disorders, including irritable bowel syndrome, ulcerative colitis, and Crohn's disease. These drugs work by blocking the action of certain enzymes in the gastrointestinal tract, which helps reduce inflammation and pain. They are typically taken orally, but can also be administered intravenously. Androisoxazole drugs are generally well-tolerated and have few side effects. Common side effects include nausea, vomiting, and diarrhea. In some cases, they may also cause liver damage or an increased risk of infection. The androisoxazole market is a rapidly growing segment of the gastrointestinal drug market. It is expected to continue to grow as more people are diagnosed with gastrointestinal disorders and as new treatments become available. Some companies in the androisoxazole market include AbbVie, AstraZeneca, Merck, Pfizer, and Takeda. Show Less Read more